XARELTO® (rivaroxaban) Information for Healthcare Professionals | XARELTO® (rivaroxaban) HCP
Discover XARELTO®, a Factor Xa inhibitor indicated to reduce stroke risk in patients with nonvalvular AF, to treat DVT & PE and for extended risk reduction, and for DVT prophylaxis after knee or hip replacement surgery.
xarelto, rivaroxaban, xarelto rivaroxaban, dvt prophylaxis, nonvalvular atrial fibrillation, nonvalvular af, reduction of stroke risk in atrial fibrillation, recurrent dvt, pulmonary embolisms, dvt pe, dvt, deep vein thrombosis dvt
Is this your site? Certify your site and update informations
